Hims & Hers Health (NYSE:HIMS) Shares Down 3.9% - What's Next?

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) shares were down 3.9% during mid-day trading on Monday . The company traded as low as $45.04 and last traded at $46.13. Approximately 9,891,331 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 23,419,942 shares. The stock had previously closed at $47.98.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on HIMS shares. Citigroup restated a "sell" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. Morgan Stanley reiterated an "equal weight" rating and set a $40.00 price objective on shares of Hims & Hers Health in a report on Wednesday, June 11th. Truist Financial set a $45.00 price objective on Hims & Hers Health in a report on Tuesday, June 24th. Piper Sandler reiterated a "neutral" rating and set a $39.00 price objective (up from $35.00) on shares of Hims & Hers Health in a report on Tuesday, May 6th. Finally, UBS Group set a $30.00 price objective on Hims & Hers Health in a report on Monday, June 23rd. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $39.58.

Hims & Hers Health Stock Up 0.8%

The stock has a market capitalization of $10.82 billion, a price-to-earnings ratio of 70.06, a P/E/G ratio of 1.76 and a beta of 2.02. The company's 50-day simple moving average is $52.62 and its 200 day simple moving average is $40.54.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.12 by $0.08. The firm had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The business's quarterly revenue was up 110.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.05 earnings per share. On average, equities analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Michael Chi sold 17,102 shares of Hims & Hers Health stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total transaction of $1,021,844.50. Following the sale, the insider directly owned 278,654 shares of the company's stock, valued at $16,649,576.50. This trade represents a 5.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Andrew Dudum sold 65,110 shares of Hims & Hers Health stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $59.22, for a total value of $3,855,814.20. Following the sale, the chief executive officer directly owned 95,105 shares in the company, valued at approximately $5,632,118.10. This trade represents a 40.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 692,006 shares of company stock valued at $34,857,872 in the last quarter. Insiders own 17.71% of the company's stock.

Institutional Investors Weigh In On Hims & Hers Health

Institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new stake in Hims & Hers Health during the fourth quarter worth about $18,048,000. O Shaughnessy Asset Management LLC acquired a new stake in Hims & Hers Health during the fourth quarter worth about $208,000. Commonwealth Equity Services LLC grew its position in Hims & Hers Health by 111.6% during the fourth quarter. Commonwealth Equity Services LLC now owns 58,894 shares of the company's stock worth $1,424,000 after buying an additional 31,062 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in Hims & Hers Health by 51.9% during the fourth quarter. PNC Financial Services Group Inc. now owns 17,225 shares of the company's stock worth $417,000 after purchasing an additional 5,885 shares during the period. Finally, Amundi lifted its stake in Hims & Hers Health by 49.1% during the fourth quarter. Amundi now owns 12,741 shares of the company's stock worth $328,000 after purchasing an additional 4,197 shares during the period. 63.52% of the stock is owned by institutional investors and hedge funds.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.